• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEPUY IRELAND - 9616671 ATTUNE CR FEM RT SZ 5 NAR CEM; ATTUNE IMPLANT : KNEE FEMORAL

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEPUY IRELAND - 9616671 ATTUNE CR FEM RT SZ 5 NAR CEM; ATTUNE IMPLANT : KNEE FEMORAL Back to Search Results
Model Number 1504-00-225
Medical Device Problem Code Use of Device Problem (1670)
Health Effect - Clinical Codes Muscular Rigidity (1968); Pain (1994); Loss of Range of Motion (2032)
Date of Event 07/14/2022
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
Product complaint # (b)(4).Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
 
Event or Problem Description
Patient had revision knee replacement for pain & stiffness.Attune primary revised and replaced with attune revision on (b)(6) 2022.Patient had original primary surgery in 2018.After initial primary surgery patient had knee stiffness with limited flexion (<90 degrees).Had multiple (x4) mua's (manipulation under unaesthetic) which did not fix the issue of stiffness.X-ray showed some signs of possible tibial loosening (lucent lines & subsidence).During removal of primary implants in revision surgery it was noted that the femur was well fixed but was sitting somewhat anterior (? patello femoral stuffing contributing to stiffness) however the tibia was somewhat loose particularly anteriorly.Femur, tibia & insert removed.Femur downsized to a size 4 to open flexion gap.Flexion extension gaps equalized.Rp stemmed femoral & tibial component used with posterior stabilized insert.Knee range of motion was past 90 degrees.Did the patient experience a post-op device malfunction? no, did the patient experience an adverse event such as infection, non-union, allergic reaction, osteoporosis, overloading, pain, degenerative diseases, bleeding or oozing? yes, did the patient require revision surgery or hardware removal? yes, facility name of original implant st john of god ballarat, was device explanted? true, hardware/explant removal due to: pain & stiffness, did patient require revision surgery? true, if yes, date of revision surgery.(b)(6) 2022, reason for revision surgery.Pain & stiffness; ? loose tibia, patient status/ outcome / consequences no, was other medical intervention (e.G.X-rays, additional procedures, prescriptions, otc, revision) required: unknown, is the patient part of a clinical study no, (b)(6) device property of none, device in possession of none, (b)(6) device property of none, device in possession of none, (b)(6) device property of none, device in possession of none by checking this box i certify that all information that are known/available has been disclosed.If any new information will be made available, the additional information will be submitted through cst.True.
 
Event or Problem Description
Affected side: right side.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This report is being submitted pursuant to the provisions of 21 cfr, part 803.This report may be based on information which has not been investigated or verified prior to the required reporting date.This report does not reflect a conclusion by depuy synthes joint reconstruction, or its employees that the report constitutes an admission that the product, depuy synthes joint reconstruction, or its employees caused or contributed to the potential event described in this report.If information is obtained that was not available for the initial report, a follow-up report will be filed as appropriate.
 
Additional Manufacturer Narrative
Product complaint # (b)(4).This medwatch report was initially submitted on (b)(6) 2022.This report is being resubmitted as this report failed submission as a result of the electronic gateway.Please reference fda ticket csh-28330 for additional details investigation summary the device associated with this complaint was not returned for examination.The x-ray review found the patients femur to be slightly anterior but no device misposition.The reported allegation cannot be confirmed.Depuy synthes considers the investigation closed at this time.Should additional information be received, the information will be reviewed and the investigation may be re-opened as necessary.Device history lot a search of the depuy nonconformance (nc) quality system found no nc¿s associated with this product/lot combination.Based on the inability to find any nc¿s against the provided product code/lot code combination, it is reasonable to conclude that there are no anomalies with regard to manufacturing or inspection contained in the device history records that would contribute to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ATTUNE CR FEM RT SZ 5 NAR CEM
Common Device Name
ATTUNE IMPLANT : KNEE FEMORAL
Manufacturer (Section D)
DEPUY IRELAND - 9616671
loughbeg ringaskiddy co.
cork
EI 
Manufacturer (Section G)
DEPUY IRELAND 9616671
loughbeg, ringaskiddy co.
cork IN
EI  
Manufacturer Contact
kate karberg
700 orthpaedic dr.
warsaw, IN 46581
3035526892
MDR Report Key15131514
Report Number1818910-2022-14491
Device Sequence Number5498979
Product Code NJL
UDI-Device Identifier10603295041283
UDI-Public10603295041283
Combination Product (Y/N)N
Initial Reporter CountryAS
PMA/510(K) Number
P830055
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Device Explanted Year2022
Serviced by Third Party (Y/N)Unknown
Reporter Type Manufacturer
Report Source Foreign,Health Professional,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 09/23/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Operator of Device Health Professional
Device Model Number1504-00-225
Device Catalogue Number150400225
Device Lot Number8656263
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 07/14/2022
Supplement Date Received by Manufacturer08/12/2022
09/22/2022
Initial Report FDA Received Date07/29/2022
Supplement Report FDA Received Date08/15/2022
12/05/2022
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured11/06/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
ATTUNE CR RP INSRT SZ 5 5MM; ATTUNE RP TIB BASE SZ 4 CEM
Outcome Attributed to Adverse Event Required Intervention;
Patient Age53 YR
Patient SexFemale
-
-